Related Experiment Video
Updated: Apr 27, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA: important player in the pathobiology of multiple myeloma
1Experimental Therapeutics, Cancer Science Institute of Singapore, No. 12-02, Centre for Translational Medicine, 14 Medical Drive, Singapore 117599 ; Yong Loo Lin School of Medicine, NUHS Tower Block level 11, 1E Kent Ridge Road, Singapore 119228.
Abstract:
Recent studies have revealed a pivotal role played by a class of small, noncoding RNAs, microRNA (miRNA), in multiple myeloma (MM), a plasma cell (PC) malignancy causing significant morbidity and mortality. Deregulated miRNA expression in patient's PCs and plasma has been associated with tumor progression, molecular subtypes, clinical staging, prognosis, and drug response in MM. A number of important oncogenic and tumor suppressor miRNAs have been discovered to regulate important genes and pathways such as p53 and IL6-JAK-STAT signaling. miRNAs may also form complex regulatory circuitry with genetic and epigenetic machineries, the deregulation of which could lead to malignant transformation and progression. The translational potential of miRNAs in the clinic is being increasingly recognized that they could represent novel biomarkers and therapeutic targets. This review comprehensively summarizes current progress in delineating the roles of miRNAs in MM pathobiology and management.
Insights
MicroRNAs (miRNAs) are crucial in multiple myeloma (MM), a plasma cell cancer. Understanding miRNA roles offers new diagnostic and therapeutic strategies for MM patients.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Multiple myeloma (MM) is a plasma cell malignancy with significant health impacts.
- MicroRNAs (miRNAs), small noncoding RNAs, are increasingly recognized for their roles in cancer.
- Aberrant miRNA expression is linked to MM progression and patient outcomes.
Purpose of the Study:
- To review the current understanding of microRNA involvement in multiple myeloma.
- To explore the diagnostic and therapeutic potential of miRNAs in MM management.
Main Methods:
- Comprehensive literature review of studies on miRNAs in multiple myeloma.
- Analysis of research on miRNA expression, function, and clinical relevance in MM.
Main Results:
- Deregulated miRNA expression correlates with MM tumor progression, subtypes, staging, prognosis, and drug response.
- Key oncogenic and tumor suppressor miRNAs regulate critical genes and pathways (e.g., p53, IL6-JAK-STAT).
- miRNAs interact with genetic and epigenetic factors, influencing MM development.
Conclusions:
- MicroRNAs play a pivotal role in the pathobiology of multiple myeloma.
- miRNAs hold significant translational potential as biomarkers and therapeutic targets for MM.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation

